Trk-IN-11

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Trk-IN-11 

Trk-IN-11 (Compound 14h) 是一种有效的 TRK 抑制剂 (IC50 = 1.4, 1.8 nM, 针对 TrkA, TrkA< sup>G595R，分别)。作为受体酪氨酸激酶 (RTK)，原肌球蛋白受体激酶 (Trk) 是实体瘤中的关键药物靶点。Trk-IN-11具有研究癌症疾病的潜力。

Trk-IN-11

Trk-IN-11 Chemical Structure

CAS No. : 2700265-62-7

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Trk-IN-11 (Compound 14h) is a potent inhibitor of TRK (IC50 = 1.4, 1.8 nM, against TrkA, TrkAG595R, respectively). As a receptor tyrosine kinase (RTK), tropomyosin receptor kinase (Trk) is a key drug target in solid tumors. Trk-IN-11 has the potential for the research of cancer disease[1].

分子量

411.43

Formula

C21H22FN5O3
CAS 号

2700265-62-7
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Fan Y, et al. Pyrizolo[1,5-a]pyrimidine derivatives of the second-generation TRK inhibitor: Design, synthesis and biological evaluation. Bioorg Med Chem Lett. 2022;63:128646.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务